Vistagen Therapeutics, Inc.
For the period ended Mar 31, 2026. Filed Jun 15, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Jun 15, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
PARTI
All trade names, trademarks and service marks appearing in this Annual Report are the property of their respective holders. Unless the context requires otherwise, references in this report to“Vistagen,” the“Company,” “we,” “us,” and“our” refer to Vistagen Therapeutics, Inc., a Nevada corporation. All references to future quarters and years in this Annual Report refer to calendar quarters and calendar years, unless reference is made otherwise.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.